AKT1 and cancer: Key oncoproteins, such as LANA, vCyc, vFLIP, and vGPCR, activate cancer hallmarks, as sustained proliferation, immune evasion, angiogenesis, and resistance to cell death, by modulating pathways such as PI3K/AKT/mTOR and NF-κB.